SCHEMBL22489583

SCHEMBL22489583

CC(C)c1nc(N(C)C)ccc1C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.45
TDP1 Q9NUW8 2/20 0.45
CYP3A4 P08684 1/20 0.45
ALOX15 P16050 1/20 0.45
TSHR P16473 1/20 0.45
MAPK1 P28482 1/20 0.45
HIF1A Q16665 1/20 0.45
HSD17B10 Q99714 1/20 0.45
NCF1 P14598 1/20 0.35
GAA P10253 2/20 0.35
MDM2 Q00987 1/20 0.34
XPO1 O14980 2/20 0.33
APAF1 O14727 1/20 0.32
AR P10275 4/20 0.31
CYP2D6 P10635 2/20 0.31
CYP2C9 P11712 1/20 0.31
CLK4 Q9HAZ1 1/20 0.31
USP2 O75604 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21139917 0.76 CYP3A4 (0.37) CYP3A4TSHRGAAXPO1CYP2D6
SCHEMBL17537351 0.76 CYP1A2 (0.49) CYP1A2TDP1CYP3A4ALOX15TSHR
SCHEMBL21733739 0.74 KDM4E (0.41) TSHRHSD17B10GAAXPO1ALDH1A1
SCHEMBL20288409 0.74 XPO1 (0.36) XPO1
SCHEMBL12763753 0.74 KIF11 (0.31) XPO1
SCHEMBL25163406 0.71 CYP11B2 (0.39) ALDH1A1PDE2A
SCHEMBL22062851 0.71 CYP1A2 (0.42) CYP1A2CYP3A4TSHRNCF1GAA
SCHEMBL21725543 0.71 AR (0.40) CYP1A2TDP1CYP3A4ALOX15TSHR
SCHEMBL11991740 0.70 DYRK1A (0.42) CYP1A2TDP1CYP3A4ALOX15TSHR
SCHEMBL24910006 0.69 PTPN1 (0.38) AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020198469-A1 METHOD FOR TREATING EPIDERMAL GROWTH FACTOR RECEPTOR-DRIVEN CANCERS WITH PROTEIN KINASE C INHIBITORS IN COMBINATION WITH AN EGFR-TYROSINE KINASE INHIBITOR IDEAYA BIOSCIENCES INC. (US) 2020-10-01 WO disclosed